Apitolisib (GDC-0980) |
|
| Synonyms: (S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one; Apitolisib; G 038390; G 038390.1; GDC 0980; GDC 0980.1; GNE 390; RG 7422 | |
| Cat. No.: A97300 | CAS No.: 1032754-93-0 |
| MDL.: | Formula: C23H30N8O3S |
| F.W.498.6 | Purity: 99％ |
| Storage: | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | POA | Enter qty and click checkbox |
| Catalog Number： | A97300 | CAS No.: | 1032754-93-0 | |
| MDL: | Formula: | C23H30N8O3S | ||
| F.W.: | 498.6 | Purity: | 99％ | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Category: | Reference Standard | ||
| Reference: | Sampath, D. et al.: Neoplasoa, 15, 694 (2013); Serova, M. et al.: Canc. Chemother. Pharm., 71, 1297 (2013); | |||
| Application: | GDC-0980 is used in the synthesis of PI3K inhibitors to treat carcinomas. | |||
| Category: | Pharmaceuticals, Intermediates & Fine Chemicals, Miscellaneous Reagents | |||